Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 7,057 | 6,765 | 0 | 7,686 | 7,238 |
| Operating Income | -7,057 | -6,765 | N/A | -7,686 | -7,238 |
| Other Income | 272 | 180 | 0 | 219 | 136 |
| Pre-tax Income | -6,785 | -6,585 | 0 | -7,467 | -7,102 |
| Net Income Continuous | -6,785 | -6,585 | N/A | -7,467 | -7,102 |
| Net Income | $-6,785 | $-6,585 | $N/A | $-7,467 | $-7,102 |
| EPS Basic Total Ops | -35.80 | -35.58 | N/A | -40.34 | -38.37 |
| EPS Basic Continuous Ops | -35.80 | -35.57 | N/A | -40.34 | -38.37 |
| EPS Diluted Total Ops | -35.80 | -35.58 | N/A | -40.34 | -38.37 |
| EPS Diluted Continuous Ops | -35.80 | -35.57 | N/A | -40.34 | -38.37 |
| EBITDA(a) | $-7,061 | $-6,800 | $N/A | $-7,774 | $-7,238 |